A randomized trial of daclatasvir in combination with asunaprevir and beclabuvir in patients with chronic hepatitis C virus genotype 4 infection. [electronic resource]
Producer: 20160125Description: 1204-6 p. digitalISSN:- 1600-0641
- Adult
- Antiviral Agents -- administration & dosage
- Benzazepines -- administration & dosage
- Carbamates
- Drug Monitoring
- Drug Resistance, Viral
- Enzyme Inhibitors -- administration & dosage
- Female
- Hepacivirus -- drug effects
- Hepatitis C, Chronic -- drug therapy
- Humans
- Imidazoles -- administration & dosage
- Indoles -- administration & dosage
- Isoquinolines -- administration & dosage
- Male
- Middle Aged
- Pyrrolidines
- Sulfonamides -- administration & dosage
- Treatment Outcome
- Valine -- analogs & derivatives
No physical items for this record
Publication Type: Clinical Trial, Phase II; Letter; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.